Detalhe da pesquisa
1.
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.
Cancer
; 130(9): 1663-1672, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127583
2.
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.
Br J Haematol
; 204(5): 1944-1952, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448009
3.
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplant.
Br J Haematol
; 202(4): 866-873, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37376789
4.
Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
Am J Hematol
; 98(10): 1571-1578, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461327
5.
AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.
Mol Ther
; 28(6): 1432-1441, 2020 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32348718
6.
Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
Br J Haematol
; 201(4): e37-e41, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36916461
7.
Targeting KCa1.1 Channels with a Scorpion Venom Peptide for the Therapy of Rat Models of Rheumatoid Arthritis.
J Pharmacol Exp Ther
; 365(2): 227-236, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29453198
8.
KCa1.1 channels regulate ß1-integrin function and cell adhesion in rheumatoid arthritis fibroblast-like synoviocytes.
FASEB J
; 31(8): 3309-3320, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28428266
9.
Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog.
Clin Immunol
; 180: 45-57, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389388
10.
Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma.
J Biol Chem
; 289(18): 12623-32, 2014 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24644290
11.
The cation channel Trpv2 is a new suppressor of arthritis severity, joint damage, and synovial fibroblast invasion.
Clin Immunol
; 158(2): 183-92, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25869297
12.
Structural plasticity of the coiled-coil domain of rotavirus NSP4.
J Virol
; 88(23): 13602-12, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25231315
13.
Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases.
FASEB J
; 28(9): 3952-64, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24891519
14.
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.
Blood Cancer J
; 14(1): 82, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38760362
15.
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience.
Blood Cancer J
; 14(1): 4, 2024 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38199987
16.
Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.
PLoS One
; 18(4): e0283996, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37040361
17.
Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience.
Transplant Cell Ther
; 29(4): 260.e1-260.e6, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36646323
18.
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.
Blood Cancer J
; 13(1): 68, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37137874
19.
Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple Myeloma.
Transplant Cell Ther
; 29(12): 757-762, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37673125
20.
Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia.
Front Immunol
; 13: 1018047, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36203567